Spine BioPharma, Inc.
PrivateLast Round
Seed Round
Jun 5, 2026
Est. Valuation
$62.4M
Total Funding Raised
$17.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Spine BioPharma, Inc. is a biopharmaceutical company that develops non-surgical, non-opiate therapies for degenerative spine-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B2C
Customer Profile
Hardware Sales, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Spine BioPharma, Inc. Comparables
Compare Spine BioPharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DiscGenics | 85% | |
| Notogen Inc. | 80% | |
| Stayble Therapeutics AB | 79% | |
Spine BioPharma, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 5, 2026 | ||||
| Early Funding | Dec 18, 2024 | ||||
| Series B | Mar 24, 2022 | ||||
| Convertible Debt | Apr 20, 2021 | ||||
| Series A | Apr 1, 2021 |
Key People
Founding team and executive leadership
Spine BioPharma, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cercano Management | Series A |
| Cercano Management | Series B |
| Viscogliosi Brothers, LLC | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2026
$385K raised in Seed Round.
- Apr 17, 2026
Monthly visitors increased 146% MoM, reaching 5.3K.
Spine BioPharma, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Spine BioPharma, Inc.'s valuation, stock price, and market status.